A clinical trial to study the effects tyrosine nutraceutical bar (CognoBar) on cognitive function in stressful environment

Operational Preparedness under Extreme Environments (OPEX): Enhancing cognitive performance at high altitude using CognoBar - CognoBar

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/046969

Enrollment

400

Registered

2022-11-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: CognoBar (Tyrosine Nutraceutical Bar): CognoBar (Tyrosine nutraceutical bar) at a dose of 6.5 g tyrosine, once on the day of recording, will be supplemented to the participants at high

Eligibility

Inclusion criteria

Inclusion criteria: Medical History:SHAPE-I Weight: 65Â±2 Kg

Exclusion criteria

Exclusion criteria: Free from any neurological disorder and cardiac problems and would not be taking any sort of psychotropic, psychoactive or any other medication during the course of the study

Design outcomes

Primary

Measure	Time frame
Effect of CognoBar (Tyrosine nutraceutical bar) on Cognitive function at High Altitude (11000 to 12000 feet)Timepoint: 8-10 week after High altitude induction	—

Secondary

Measure	Time frame
Effect of CognoBar (Tyrosine nutraceutical bar) on Cognitive function at Very High Altitude (13000 to 14000 feet)Timepoint: 8-10 week after Very High altitude induction	—

Countries

India

Contacts

Public ContactDr Somnath Singh

Defence Institute of Physiology and Allied Sciences, Defence Research and Development Organization

kishu16in@gmail.com011-23883206

Outcome results